Drugs for Neglected Diseases initiative (DNDi)

organization

Last mentioned: 2h ago

Timeline

  1. Rollout Milestone

    Acoziborole enters the final stages of regulatory rollout for endemic regions.

  2. Trial Results

    Phase 2/3 clinical trial results for Acoziborole show high efficacy.

  3. Fexinidazole Approval

    First all-oral 10-day treatment for sleeping sickness is approved.

  4. Research Begins

    DNDi starts screening compounds for a single-dose HAT treatment.

Stories mentioning Drugs for Neglected Diseases initiative (DNDi) 1